The mucosal and systemic immune responses in chickens orally immunised with Campylobacter jejuni antigen entrapped in poly-lactide-co-glycolide microparticles by Noor, Susan Maphilindawati
 264 
THE MUCOSAL AND SYSTEMIC IMMUNE RESPONSES IN CHICKENS 
ORALLY IMMUNISED WITH CAMPYLOBACTER JEJUNI ANTIGEN 
ENTRAPPED IN POLY-LACTIDE-CO-GLYCOLIDE MICROPARTICLES 
SUSAN MAPHILINDAWATI NOOR 
Research Institute for Veterinary Science 
Jalan R.E. Martadinata 30, P.O. Box 151, Bogor 16114, Indonesia 
 
 
(Received by the editor 22 October 1998) 
ABSTRAK 
NOOR, S.M. 1998. Respon kekebalan mukosal dan sistemik pada ayam setelah imunisasi oral dengan antigen Campylobacter 
jejuni dalam poly-lactide-co-glycolide mikropartikel. Jurnal Ilmu Ternak dan Veteriner 3 (4): 264-269. 
Untuk mengimunisasi ayam secara peroral diperlukan teknik penyediaan imunogen yang sesuai agar tanggap-kebal yang 
diperoleh menjadi optimal. Teknik penyediaan antigen dengan mikropartikel merupakan suatu cara untuk meningkatkan efikasi 
kerja antigen vaksin peroral. Penelitian ini menguji sifat antigenik Campylobacter jejuni untuk menaikkan tanggap-kebal 
mukosal dan sistemik (humoral) pada ayam. Kelompok A (5 buah telur ayam berembrio) diimunisasi dengan formulasi antigen 
C. jejuni dalam mikropartikel poly-lactide-co-glycolide (PLG) pada hari ke-17 masa inkubasi ke dalam cairan amnion dan 
booster oral diberikan pada hari ke-7 setelah menetas. Kelompok B, telur berembrio diimunisasi dengan antigen campylobacter 
dilarutkan dalam PBS, dengan perlakuan seperti pada Kelompok A. Tanggap-kebal vaksinasi diamati pada hari ke-14 dengan 
mendeteksi kekebalan humoral dengan teknik ELISA dan mendeteksi kekebalan mukosal dengan teknik histologi fluoresensi. 
Titer antibodi (anti-campylobacter) IgG dan IgA dalam serum dan juga titer antibodi IgA dalam cairan empedu dan kerokan 
usus secara nyata lebih tinggi (P<0,05) pada ayam Kelompok A dibandingkan dengan Kelompok B. Jumlah imunoglobulin total 
yang terkandung di dalam sel untuk isotipe IgG, IgM dan IgA dalam ileum ayam Kelompok A juga meningkat secara nyata 
(P<0,05) dibandingkan dengan Kelompok B, tetapi dalam duodenum dan limpa peningkatan sel itu tidak nyata.  
Kata kunci : Campylobacter jejuni, mikropartikel poly-lactide-co-glycolide, imunisasi oral, ayam 
ABSTRACT 
NOOR, S.M. 1998. The mucosal and systemic immune responses in chickens orally immunised with Campylobacter jejuni 
antigen entrapped in poly-lactide-co-glycolide microparticles. Jurnal Ilmu Ternak dan Veteriner 3 (4): 264-269. 
An oral immunisation in chickens with antigen entrapping in biodegradable microparticles was evaluated in order to achieve 
optimal antibody responses following oral vaccination. This study was adapted to Campylobacter jejuni antigen in chickens to 
observe its stimulation both mucosal and systemic immune responses. A group of 5 embryonated chicken eggs was immunised 
with heat-killed C. jejuni entrapped in poly-lactide-co-glycolide (PLG) microparticles at day 17 of incubation deposited into the 
amniotic fluid. Seven days after hatching the chickens were oral boostered, these was design to as Group A. In the Group B, 
each embryonated egg was immunised with soluble C. jejuni as in the same as Group A. Immune responses of post vaccination 
were observed at day-14, the humoral immunity was evaluated with an ELISA and whereas mucosal antibody response was 
detected by fluorescent histology. The serum IgG and IgA antibody responses, and also the bile and intestinal scrapping IgA 
antibody responses to campylobacter in Group A were significantly higher than those of the soluble antigen of Group B 
(P<0.05). Total number of immunoglobulin-containing cells for IgG, IgM, and IgA isotypes in the ileum in Group A chickens 
were also significantly higher than those of Group B (P<0.05) but was not in the duodenum and spleen. 
Key words : Campylobacter jejuni, poly-lactide-co-glycolide microparticles, oral immunisation, chickens 
 
INTRODUCTION 
In chickens, vaccination by means of 
intramuscular or subcutaneous injection has some 
disadvantages, these are expensive, labour intensive, 
and requires qualified personnel. Vaccines containing 
synthetic recombinant protein were reported to be 
poorly immunogenic for stimulating mucosal immune 
responses (MOWAT et al., 1991).  Most adjuvants are 
not suitable to all immunogens and to stimulate 
humoral   immune   responses    (ADIBERT et al., 1993).  
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Moreover, the available adjuvants, such as Freund's 
incomplete adjuvant, have negative effects, such as 
local granulomas in the site of injection, fever, pain and 
possibly malignancies (BEEBE et al., 1972). 
On the other hand, oral immunisation by drinking 
water in chickens has advantage of being fast, in 
inducing a mucosal immunity and reducing costs. 
However, oral route immunisation produced a poor 
antigen-specific secretory IgA response unless 
prolonged feeding or high dose of antigen was used 
(PROWSE et al., 1993). To overcome that problem 
recent techniques for controlling poultry diseases have 
been developed by improving vaccines efficacy and 
antigen delivery technique. One of the alternatives 
method for antigen delivery technique at mucosal sites 
in chickens is embryonal vaccination (PROWSE et al., 
1993). Another method that has been developed in 
mammalian is a biodegradable microparticle of poly-
lactide-co-glycolide (PLG) (ELDRIDGE et al., 1989; 
MORRIS et al., 1994; O'HAGAN, 1994).  
The biodegradable microparticles have been 
considered as a potential method for releasing antigen 
in long-term to stimulate immune responses (MORRIS et 
al., 1994). This method has several benefits for oral 
immunisation, for enhancing the immune response of 
poorly immunogenic antigen (GILLEY et al., 1992; 
O'HAGAN et al., 1989), reducing total antigen dose 
required to achieve adequate immunity, protecting 
antigen from the acid and enzymatic digestion in the 
gastrointestinal tract (MORRIS et al., 1994), and 
enhancing antigen absorbtion by Peyer patch's (PP) and 
stimulating secretory immune responses (O'HAGAN, 
1990; ELDRIDGE et al., 1990).  
The mechanism of antigen released from 
microparticles is supposed by diffusion through matrix 
pores and matrix degradations. The antigen released 
depends on polymer composition and molecular weight 
(MORRIS et al., 1994; O'HAGAN et al., 1991). 
Enhancement of antibody response is affected by size 
of microparticles mixtured (MORRIS et al., 1994). Based 
on a study reported by ELDRIDGE et al. (1990), 
microparticles larger than 5 µm in diameter will remain 
in the PP from 1 to 35 days after administration, with 
the high peak at 1 to 4 days. 
Previous study indicated that biodegradable 
microparticles containing antigen used in oral 
vaccination might enhance mucosal and systemic 
immune responses (ELDRIDGE et al., 1989; O'HAGAN et 
al., 1991; O'HAGAN et al., 1993), but it has not used in 
chickens. The present study reported here was the 
efficacy of PLG biodegradable microparticles as an oral 
delivery vehicle of Campylobacter jejuni antigen in 
inducing mucosal and systemic immune responses in 
chickens. 
MATERIALS AND METHODS 
 
Animals 
 
Embryonated broiler eggs obtained from Ingham 
poultry hatchery (Casula, Australia) were used in this 
experiment. They were placed in an incubator at 37.4oC 
with humidity of 59 to 76%. Eggs were incubated at 
one time were used for treatment and control groups. 
These embryonated eggs were divided into two groups 
(Group A and B), each consist of 5 eggs. 
 
Microparticles preparation 
 
The PLG (Polyscientific, USA) microparticles 
entrapping C. jejuni antigens was prepared by solvent 
evaporation from an oil-in-water emulsion as 
previously described (JEFFERY et al., 1993). Briefly, 
200 ml of 0.1% PVA (Polyvinyl alcohol) (Sigma 
69F0692, MW 30,000-70,000) was placed in a 500 ml 
beaker and homogenised with ultra Turrax T 25 blender 
at 450 RPM (Solution 1). One ml of heat-killed C. 
jejuni was added to 20 ml PLG and homogenised at 
13,500 RPM for 1 min, the 15 ml of 5% PVA was then 
added and homogenised for 30 seconds at 450 RPM 
(Solution 2). The Solution 2 was added to Solution 1 
and mixed by magnetic stirrer at room temperature 
(RT) overnight to allow solvent evaporation and 
microparticle formation. Microparticles were collected 
the next day and washed with phosphate-buffered saline 
(PBS) (pH 7.3), non-entrapped antigens was removed 
by centrifuging at 2,500 RPM for 10 min at 21oC. The 
microsphere fractions were collected and rediluted in 
PBS, and then measured by laser diffractometry 
(Malvern Laser Sizer 2600 D). 
 
Immunisation protocol 
 
Each egg of Group A was injected at day 17 of 
incubation with 108 colony-forming-units (cfu) of heat-
killed C. jejuni entrapped in PLG microparticles, 0.5ml 
of antigen was deposited into the amniotic fluid. Seven 
days after hatching, each chicken was given oral 
booster of 1 ml of the same antigen as used in the 
primary of egg injection. Similar procedure was done to 
Group B with soluble C. jejuni antigen.  
 
Sample collections 
 
Serum, bile, and intestinal scrapping (IS) samples 
were collected at day 14 to determine antibody 
responses.     Under   anaesthesia  treatment  with  ether  
inhalation just before killing chicken blood sample was  
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collected by cardiac puncture for each animal and then 
chickens were euthanised. Bile was aspirated from the 
gall bladder after opened the chicken abdomen. The 
jejunum was removed immediately and rinsed with PBS 
and mucosal scrapping samples were collected by 
opening segments of intestine on to moistened filter 
paper. While, tissue section samples of ileum and 
duodenum were fixed in cold ethanol.  
 
Antibody assay 
 
The specific anti-campylobacter IgG, IgM, and 
IgA antibody responses of each sample were 
determined by ELISA. The ELISA antigen was 
obtained from Dr. Philip Widders (V.I.A.S., Australia). 
Briefly, a culture of C. jejuni was centrifuged at 
10.000g and the supernatant filtered through a 0.22 µm 
filter. The protein content was confirmed by performing 
polyacrylamide gel electrophoresis in sodium dodecyl 
sulphate (SDS) (Bacto, Liverpool, Auastralia) followed 
by staining with commasie blue. 
The ELISA procedures for detecting those anti-
campylobacter antibody responses had been previously 
validated for anti-campylobacter IgG, IgM, and IgA 
antibodies (NOOR et al., 1995), briefly: The wells of 
microtiter ELISA plates NUNC (Medos Company, 
Burwood, Australia) were coated with 100 µl per well 
of C. jejuni flagellin antigen (14 mg per ml) diluted in 
PBS (1 in 300) and incubated at 4oC for overnight. The 
wells were washed twice with PBS-Tween-20 (PBST) 
(Sigma-Aldrich, Castle Hill, Australia) and once with 
distilled water. Each well was blocked with 100 µl of 
PBST containing 0.01% ovalbumin (Sigma) at 37oC for 
1 hr. After washing with PBST as previous step 100µl 
of appropiate diluted serum samples was added (serum 
and IS were diluted 1:5, bile was diluted 1:100 in PBST 
containing 0.01% ovalbumin). After incubation at 37oC 
as before, plates were washed 3 times with PBST, 100 
µl of goat anti-chicken IgG horseradish peroxidase 
(HRP) conjugates (Bethyl Laboratories, Montgomery, 
USA) was added at working dilution 1:1000 in PBS. 
While, to detect IgM response, anti-chicken IgM HRP 
was diluted 1:500, whereas to detect IgA response, anti-
chicken IgA HRP was diluted 1:100. Plates were 
incubated at 37oC for 1 hr and washed as before, 
enzyme substrate of 2,2'-azino-di-[3-ethyl-
benzthiazoline sulphonate] (ABTS) was added into 
each well and incubated at 37 oC for 40 min. The 
reaction was stopped with 1% sodium dodecyl sulphate 
diluted with distilled water 
The reactions were determined on ELISA reader 
of an automated plate reader (Biorad model 3550-UV). 
The optical density (OD) of each well was determined 
at 405 nm on each well after the instrument was zeroed  
with unreacted substrate. Results were expressed as a 
percentage of the OD of a high positive standard from 
hyperimmunised chickens. 
 
Immunofluorescent procedures 
 
The tissue section of spleen, duodenum and ileum 
were embedded in paraffin as previously described by 
SAINTE-MARIE (1962) to examine the immunoglobulin-
containing cells using a direct fluorescent antibody 
technique. Briefly, the embedded tissue were dewaxed, 
rehydrated and stained for 20 min in the humid 
chamber with 40 µl of FITC-labelled goat anti-chicken 
IgA isotypes (Bethyl) at working dilution 1:50 in PBS. 
Slides were then washed in PBS for 1h, then mounted 
under a coverslip with phosphate-buffered glycerol. To 
examine the IgM-containing cells, the tissues were 
stained with FITC-labelled goat anti-chicken IgM 
isotypes (Bethyl) at working dilution 1:50, whereas for 
IgG-containing cells, FITC-labelled goat anti-chicken 
was diluted 1:20. 
The immunoglobulin-containing cells were 
counted under fluorescence microscopy using an 
Axioskop 20 microscope (Zeiss, Germany) with 
incident light illumination with minimum of 30 high 
power fields (hpf). The immunoglobulin containing-
cells of spleen cells were observed and counted and 
expressed as cells per field diameter. In intestinal 
tissues cells were counted in a minimum of 30 scans 
each of one field diameter 540 µm from the muscularis 
mucosae to the tips of the villi. The mean number of 
cells per each scan was then converted into cells/cm of 
intestine in the plane section as previously described 
(HUSBAND, 1982). 
 
Statistics 
 
Statistical analysis was carried out using a single 
factor Analysis of variance (Anova) to determine the 
statistical significance of differences between and 
within groups of experimental chickens (STEEL and 
TORRIE, 1980). 
RESULTS 
The ELISA results were expressed as a percentage 
of the optical density of a high positive standard 
prepared from pooled sera from hyperimmunised. The 
protein percentage of anti-campylobacter IgG, IgM and 
IgA antibody responses in serum, bile and IS of 
chickens each group are presented in Table 1. The 
result showed that the high percentage of anti-
campylobacter antibody were detected in serum, bile 
and IS of chickens immunised with  C. jejuni  antigen  
entrapped  in  PLG (Group A). 
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Table 1. The means of protein percentage of IgG, IgM and IgA antibody responses in serum, bile and IS of chickens injected 
with C. jejuni antigen 
Group of  chicken Serum Bile IS 
 % IgG % IgM % IgA % IgA % IgA 
A 84.75±8.93* 30.78±6.82ns 38.90±6.82* 5.43±1.10* 24.08±4.36* 
B 53.59±6.13 10.19± 2.81 16.69±2.04 1.46±0.22 12.27±3.61 
A   = Vaccinated with C. jejuni antigen encapsulated in PLG microparticles 
B   = Vaccinated with soluble C. jejuni antigen 
IS  = Intestinal scrapping 
Result shown as the means of % positive std. ± SE 
Significance: * = P<0.05,  ns = not significant 
 
 
Table 2.   The numbers of immunoglobulin-containing cells for IgG, IgM and IgA isotypes in the duodenum, ileum and spleen 
of chickens following oral vaccination with C. jejuni antigen 
Organs  Group A Group B 
 IgG IgM IgA IgG IgA D 
Duodenum # 1.65±1.65ns  42.17±10.41ns 132.31±61.53ns 3.03±3.03 18.43±2.93 32.32±2.70 
Ileum # 11.82±1.22* 28.79±3.46* 37.88±4.07* 1.52±1.52 5.81±5.81  9.58±2.91 
Spleen  3.09±1.38ns 13.04±1.13ns 7.78±2.77ns 1.28±1.28 12.83±3.66 2.34±0.58 
A   = Vaccinated with antigen encapsulated in PLG microparticles 
B   = Vaccinated with soluble antigen 
Significance: *= P<0.05, ns= not significant, # =(cells/cm ± SE), ## =(cells/hpf ± SE) 
 
The results obtained from chickens in Group A, 
indicate that oral immunisation with PLG micro-
particles entrapping C. jejuni antigen induced 
significantly higher levels of serum IgG and IgA 
specific antibody to campylobacter than those of 
equivalent amounts of soluble antigen in control 
chickens (Group B) (P<0.05). However, the serum IgM 
levels in chickens immunised with and without 
microparticles entrapping antigen were not significantly 
different (P>0.05).  
The IgA antibody response in bile and IS were 
also significantly higher (P<0.05) following 
immunisation with campylobacter entrapped in PLG 
microparticles compared with those of immunised 
chickens with soluble C. jejuni antigen. 
The appearance of immunoglobulin-containing 
cells associated with IgM and IgA isotypes in the ileum, 
duodenum and spleen after oral immunisation with C. 
jejuni antigen encapsulated in PLG microparticles is 
shown in Table 2. There were significant increases  in 
the number of Ig-containing cells for IgG, IgM and IgA 
isotypes in the ileum of immunised chickens with 
microparticles-encapsulated antigen (Group A) 
compared with those of immunised chickens with 
soluble antigen (Group B) (P<0.05). However, in the 
duodenum and the spleen there was no significant 
difference for IgG, IgM or IgA-containing cells 
(P>0.05). 
DISCUSSION 
The previous studies reported that entrapment of 
antigen in the PLG microparticles led to the elevation 
of the production of IgG and secretory IgA antibody 
responses following oral immunisation in small animal 
experiments (CHALLACOMBE et al., 1992; O'HAGAN et 
al., 1993), similarly. The present study, immunised 
chickens with campylobacter entrapped in the PLG 
microparticles displayed elevated serum IgG and IgA 
antibody responses and as well as elevated the levels of 
IgA antibody secretion in bile and intestinal responses, 
confirming that PLG microparticles are potent inducers 
of local and systemic antibody responses when 
administered orally. These responses were reflected in a 
dramatic increase in total of immunoglobulin-
containing cells detected by fluorescent histology, 
particularly those associated with IgG, IgM, and IgA 
isotypes in the ileum of chickens which were 
SUSAN MAPHILINDAWATI NOOR : The Mucosal and Systemic Immune Responses in Chickens Orally Immunised 
 268 
immunised with microparticles-encapsulated C. jejuni 
antigen. 
The ability of antigen entrapped in microparticles 
to induce systemic IgA antibody response and IgA 
antibody-containing cells response following oral 
administration suggested that it might be due to the 
uptake of microparticles containing antigen by the 
lymphoid tissue of Peyer's patches (PP) in the intestine. 
It was reported by O'HAGAN (1990), microparticles 
containing antigens were taken up by PP following oral 
administration in mice. The uptake of the antigen 
depended on the size of microparticles. The range of 
particle diameter between 5 to 10 µm was required to 
achieve the optimal stimulation of mucosal immunity. 
Microparticles which are greater than 10 µm in 
diameter will not be taken up by the PP, and less than 
5µm will be passed directly to mesenteric lymph nodes 
and to the spleen (ELDRIDGE et al., 1991). In this 
experiment, the average diameter size of 6.05 µm was 
assumed that this size was suitable for inducing 
systemic IgG and IgA antibody in serum, and in 
intestinal scrappings and also increase the number of 
immunoglobulin-containing cells of all isotypes in the 
ileum. 
Although the number of immunoglobulin-
containing cells for IgM and IgA isotypes in the 
duodenum of immunised chickens with microparticles-
entrapped C. jejuni antigen were still higher than those 
of immunised chickens with soluble antigen, there was 
no significant difference. The failure of the stimulation 
of immunoglobulin-containing cells in the duodenum 
might be explained by the lack of lymphoid tissue in the 
duodenum (BEFUS et al., 1980). Whereas, the absence 
of immunoglobulin-containing cells in the spleen is 
probably also associated with the particle size of the 
microparticles (JENKINS et al., 1994). 
The results described above demonstrated that 
biodegradable microparticles entrapping antigen 
preparation stimulates the humoral and mucosal 
immunity of chickens higher than those of the soluble 
antigen. The entrapping antigen in microparticles PLG 
technique has a great deal of potential used a vaccine 
preparation in future, particularly in the field of oral 
vaccination. 
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